Optimize IAS
  • Home
  • About Us
  • Free Initiatives
    • Daily Practice Sheets
    • Daily Prelims Notes
    • Prelims Power Play
    • Mains Factly
    • Sunday Essay Sadhna
  • Courses
    • Mains Master Notes
    • Prelims Test Series
      • Laqshya 2024
    • Integrated Guidance 2024
      • ARJUNA PRIME 2024
    • Daily Answer Writing
  • Downloads
    • Important Topics List for Prelims 2023
    • Daily Prelims Notes Compilation
    • Daily Practice Sheet Compilation
    • PPP Compilation
    • PSIR Notes
    • General Studies Notes
    • UPSC Mains Previous Year Papers
  • Portal Login
  • Home
  • About Us
  • Free Initiatives
    • Daily Practice Sheets
    • Daily Prelims Notes
    • Prelims Power Play
    • Mains Factly
    • Sunday Essay Sadhna
  • Courses
    • Mains Master Notes
    • Prelims Test Series
      • Laqshya 2024
    • Integrated Guidance 2024
      • ARJUNA PRIME 2024
    • Daily Answer Writing
  • Downloads
    • Important Topics List for Prelims 2023
    • Daily Prelims Notes Compilation
    • Daily Practice Sheet Compilation
    • PPP Compilation
    • PSIR Notes
    • General Studies Notes
    • UPSC Mains Previous Year Papers
  • Portal Login

Medicines Patent Pool deal to make cancer drug cheaper

  • June 23, 2023
  • Posted by: OptimizeIAS Team
  • Category: DPN Topics
No Comments
Print Friendly, PDF & Email

 

 

Medicines Patent Pool deal to make cancer drug cheaper

Subject : Science and technology

Section: Health

Concept:

  • The Medicines Patent Pool (MPP) has signed sub-licence agreements with the India-based companies Eugia, Hetero and Dr. Reddy’s Laboratories, along with the Indonesian firm BrightGene, to make generic versions of the drug Nilotinib of the Switzerland-based pharmaceutical corporation Novartis.
  • The drug Nilotinib is used for the treatment of chronic myeloid leukaemia, which is a type of blood cancer and the move is expected to make certain cancer drugs more accessible and cheaper for patients.
  • Nilotinib is sold under the brand name Tasigna and marketed worldwide by Novartis.
  • According to the recent announcement, the selected manufacturers can make generic versions of Nilotinib in India and seven middle-income countries and can also supply it in 44 territories included in the licence through a non-exclusive licence agreement, subject to local regulatory authorisation.

Medicines Patent Pool

  • The Medicines Patent Pool (MPP) is a United Nation-backed international organisation founded in July 2010, based in Geneva, Switzerland.
  • Through its innovative business model, MPP partners with civil society, governments, international organisations, industry, patient groups, and other stakeholders, to prioritise and license needed medicines and pool intellectual property to encourage generic manufacture and the development of new formulations.
  • Its public health driven business model aims to lower the prices of HIV, tuberculosis and hepatitis C medicines and facilitate the development of better-adapted HIV treatments through voluntary licensing and patent pooling.
  • Its goal is to improve access to affordable and appropriate HIV, hepatitis C and tuberculosis medicines in low- and middle-income countries (LMIC).
  • Economics research finds evidence that the pool increases generic diffusion in LMIC and upstream innovation.
Medicines Patent Pool deal to make cancer drug cheaper Science and tech
Print Friendly, PDF & Email

Recent Posts

  • Prelims Power Play 21 September 2023 September 21, 2023
  • Daily Practice Sheet 21 September 2023 September 21, 2023
  • Discuss the environmental impact of sand mining in India. September 21, 2023
  • What do you understand by debt crisis? Why so many countries are facing it? What is the world doing about it? September 21, 2023
  • Indian diaspora has scaled new heights in the West. Describe its economic and political benefits for India.  September 21, 2023
  • What do you understand by diaspora diplomacy? Discuss India’s policy towards diaspora. September 21, 2023
  • Examine the growing importance of Vietnam for India Pacific. September 21, 2023
  • Why Indian and Vietnam need each other? September 21, 2023
  • What are parliamentary privileges? What purpose do they serve? Do we need to codify them? September 21, 2023
  • What was the JMM bribery case? Why is SC reviewing it again? September 21, 2023

About

If IAS is your destination, begin your journey with Optimize IAS.

Hi There, I am Santosh I have the unique distinction of clearing all 6 UPSC CSE Prelims with huge margins.

I mastered the art of clearing UPSC CSE Prelims and in the process devised an unbeatable strategy to ace Prelims which many students struggle to do.

Free Initiatives

  • Daily Practice Sheets
  • Daily Prelims Notes
  • Mains Factly
  • Prelims Power Play
  • Sunday Essay Sadhna

My Proven Strategy

  • Interview Strategy
  • Mains Strategy
  • Motivational
  • Prelims Strategy

Contact us

moc.saiezimitpo@tcatnoc

For More Details

Work with Us

Connect With Me

Santosh Pandey Quora Santosh Sir Telegram Santosh Sir Youtube Optimize IAS Instagram

Course Portal
Search